-+ 0.00%
-+ 0.00%
-+ 0.00%

Gyre Therapeutics Sees FY2026 Sales $100.500M-$111.000M vs $146.133M Est

Benzinga·03/12/2026 10:17:38
Listen to the news
Gyre Therapeutics (NASDAQ:GYRE) sees FY2026 sales of $100.500 million-$111.000 million vs $146.133 million analyst estimate.